risperidone has been researched along with Deep Vein Thrombosis in 4 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risperidone is a second-generation atypical antipsychotic and there have been case reports of risperidone-associated deep vein thrombosis, most of them reporting the complication from 2 weeks to a few months of initiation of therapy." | 5.62 | Deep vein thrombosis on the fourth day of risperidone therapy. ( George, M; Konnakkaparambil Ramakrishnan, K, 2021) |
| " Several studies suggest an association between venous thromboembolism and the use of antipsychotic drugs, especially clozapine, but the biological mechanisms are unknown." | 3.74 | In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation. ( Axelsson, S; Eriksson, AC; Hägg, S; Lindahl, TL; Whiss, PA, 2007) |
| "Risperidone is a second-generation atypical antipsychotic and there have been case reports of risperidone-associated deep vein thrombosis, most of them reporting the complication from 2 weeks to a few months of initiation of therapy." | 1.62 | Deep vein thrombosis on the fourth day of risperidone therapy. ( George, M; Konnakkaparambil Ramakrishnan, K, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konnakkaparambil Ramakrishnan, K | 1 |
| George, M | 1 |
| Jullian-Desayes, I | 1 |
| Roselli, A | 1 |
| Lamy, C | 1 |
| Alberto-Gondouin, MC | 1 |
| Janvier, N | 1 |
| Venturi-Maestri, G | 1 |
| Kosehasanogullari, SG | 1 |
| Akdede, B | 1 |
| Akvardar, Y | 1 |
| Akan, M | 1 |
| Tunca, Z | 1 |
| Axelsson, S | 1 |
| Hägg, S | 1 |
| Eriksson, AC | 1 |
| Lindahl, TL | 1 |
| Whiss, PA | 1 |
4 other studies available for risperidone and Deep Vein Thrombosis
| Article | Year |
|---|---|
Deep vein thrombosis on the fourth day of risperidone therapy.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Male; Risperidone; Schizophrenia, Paranoid; Venous Th | 2021 |
Rhabdomyolysis with Acute Renal Failure and Deep Vein Thrombosis Induced by Antipsychotic Drugs: A Case Report.
Topics: Acute Kidney Injury; Antipsychotic Agents; Humans; Loxapine; Male; Psychotic Disorders; Rhabdomyolys | 2015 |
Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
Topics: Anemia, Hypochromic; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; beta-Thalassemia; | 2007 |
In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Blood Coagulation; Blood Platelets; Clozapine; D | 2007 |